October 1, 2024 Investor Beware: Port Strike Puts Key Stocks And Sectors At Risk
September 30, 2024 Market Movers: Jobs Report and Key Earnings in Focus
September 19, 2024 Federal Reserve’s Aggressive Move Hints At Bold Economic Strategy
Apple: Investors Betting That ‘Things Are Different This Time’
Nvidia With A 70% Yield? Why I Chose NVDY
Microsoft Stock: Q1 FY2025 Earnings Will Likely Surprise You
Tesla: Slow Q3, But Cybercab Event Signals Growth Ahead
October 3, 2024 Your Path to Profits: The Best Trading Platforms for New Traders
October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
Aptevo Therapeutics (APVO) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: October 16, 2024 (05:44)
Sector: HealthcareThe share price of Aptevo Therapeutics Inc. (APVO) now
Are you interested in Aptevo Therapeutics Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aptevo Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Aptevo Therapeutics share be worth in 2024 - 2028?
When should I take profit in Aptevo Therapeutics stock? When should I record a loss on Aptevo Therapeutics stock? What are analysts' forecasts for Aptevo Therapeutics stock? What is the future of Aptevo Therapeutics stock? We forecast Aptevo Therapeutics stock performance using neural networks based on historical data on Aptevo Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Aptevo Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Aptevo Therapeutics shares. This happens once a day.
Historical and forecast chart of Aptevo Therapeutics stock
The chart below shows the historical price of Aptevo Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Aptevo Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Aptevo Therapeutics Inc is a clinical-stage biotechnology company. It focuses on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. The company develops its drug candidates using its ADAPTIR platform. The products under its pipeline are APVO436, which targets CD123 and CD3 and redirects T-cell cytotoxicity to the tumor; ALG.APV-527, for the treatment of a broad spectrum of cancers over-expressing the 5T4 tumor antigen, including mesothelioma, non-small-cell-lung, head & neck, pancreatic, renal, ovarian, and bladder cancers; and APVO603.
Aptevo Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Oct 18 | 0.15 | 0.15 | 0.15 | 4.54 |
| Oct 19 | 0.15 | 0.15 | 0.16 | 7.75 |
| Oct 20 | 0.15 | 0.15 | 0.15 | 5.62 |
| Oct 21 | 0.15 | 0.14 | 0.15 | 6.70 |
| Oct 22 | 0.15 | 0.14 | 0.15 | 6.70 |
| Oct 23 | 0.15 | 0.15 | 0.16 | 7.78 |
| Oct 24 | 0.16 | 0.15 | 0.17 | 7.34 |
| Oct 25 | 0.16 | 0.16 | 0.17 | 6.68 |
| Oct 26 | 0.17 | 0.16 | 0.17 | 8.71 |
| Oct 27 | 0.16 | 0.15 | 0.17 | 11.55 |
| Oct 28 | 0.16 | 0.16 | 0.17 | 5.91 |
| Oct 29 | 0.16 | 0.16 | 0.17 | 7.28 |
| Oct 30 | 0.17 | 0.16 | 0.17 | 4.62 |
| Oct 31 | 0.17 | 0.17 | 0.18 | 5.19 |
| Nov 01 | 0.17 | 0.17 | 0.18 | 5.64 |
| Nov 02 | 0.18 | 0.17 | 0.18 | 5.05 |
| Nov 03 | 0.19 | 0.18 | 0.19 | 6.86 |
| Nov 04 | 0.18 | 0.18 | 0.19 | 7.01 |
| Nov 05 | 0.18 | 0.17 | 0.18 | 4.99 |
| Nov 06 | 0.17 | 0.16 | 0.17 | 7.35 |
| Nov 07 | 0.17 | 0.16 | 0.17 | 6.92 |
| Nov 08 | 0.16 | 0.16 | 0.17 | 5.23 |
| Nov 09 | 0.17 | 0.16 | 0.17 | 5.64 |
| Nov 10 | 0.17 | 0.16 | 0.17 | 6.65 |
| Nov 11 | 0.17 | 0.17 | 0.18 | 8.88 |
| Nov 12 | 0.18 | 0.17 | 0.19 | 10.44 |
| Nov 13 | 0.17 | 0.17 | 0.18 | 6.64 |
| Nov 14 | 0.17 | 0.16 | 0.18 | 8.01 |
| Nov 15 | 0.16 | 0.16 | 0.17 | 5.36 |
| Nov 16 | 0.17 | 0.16 | 0.17 | 10.08 |
Aptevo Therapeutics Daily Price Targets
Aptevo Therapeutics Stock Forecast 10-18-2024.
Forecast target price for 10-18-2024: $0.15.
Positive dynamics for Aptevo Therapeutics shares will prevail with possible volatility of 4.341%.
Pessimistic target level: 0.15
Optimistic target level: 0.15
Aptevo Therapeutics Stock Forecast 10-19-2024.
Forecast target price for 10-19-2024: $0.15.
Positive dynamics for Aptevo Therapeutics shares will prevail with possible volatility of 7.193%.
Pessimistic target level: 0.15
Optimistic target level: 0.16
Aptevo Therapeutics Stock Forecast 10-20-2024.
Forecast target price for 10-20-2024: $0.15.
Negative dynamics for Aptevo Therapeutics shares will prevail with possible volatility of 5.325%.
Pessimistic target level: 0.15
Optimistic target level: 0.15
Aptevo Therapeutics Stock Forecast 10-21-2024.
Forecast target price for 10-21-2024: $0.15.
Negative dynamics for Aptevo Therapeutics shares will prevail with possible volatility of 6.277%.
Pessimistic target level: 0.14
Optimistic target level: 0.15
Aptevo Therapeutics Stock Forecast 10-22-2024.
Forecast target price for 10-22-2024: $0.15.
Positive dynamics for Aptevo Therapeutics shares will prevail with possible volatility of 6.281%.
Pessimistic target level: 0.14
Optimistic target level: 0.15
Aptevo Therapeutics Stock Forecast 10-23-2024.
Forecast target price for 10-23-2024: $0.15.
Positive dynamics for Aptevo Therapeutics shares will prevail with possible volatility of 7.221%.
Pessimistic target level: 0.15
Optimistic target level: 0.16
APVO (APVO) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Nov. | 0.15 | 0.14 | 0.16 | 14.19 |
| Dec. | 0.16 | 0.14 | 0.17 | 13.89 |
Aptevo Therapeutics forecast for this year
Aptevo Therapeutics Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $0.148349. Pessimistic: $0.14. Optimistic: $0.16
Aptevo Therapeutics Stock Prediction for Dec 2024
An uptrend is forecast for this month with an optimal target price of $0.157932. Pessimistic: $0.14. Optimistic: $0.17
Aptevo Therapeutics (APVO) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.17 | 0.16 | 0.18 | 12.11 |
| Feb | 0.18 | 0.16 | 0.20 | 19.29 |
| Mar | 0.17 | 0.15 | 0.18 | 18.89 |
| Apr | 0.17 | 0.15 | 0.19 | 17.73 |
| May | 0.19 | 0.17 | 0.22 | 23.30 |
| Jun | 0.18 | 0.17 | 0.20 | 16.76 |
| Jul | 0.17 | 0.16 | 0.18 | 14.51 |
| Aug | 0.15 | 0.13 | 0.17 | 22.21 |
| Sep | 0.16 | 0.15 | 0.18 | 14.84 |
| Oct | 0.17 | 0.15 | 0.17 | 11.66 |
| Nov | 0.16 | 0.15 | 0.16 | 10.32 |
| Dec | 0.17 | 0.16 | 0.18 | 11.73 |
Aptevo Therapeutics (APVO) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.19 | 0.18 | 0.21 | 13.93 |
| Feb | 0.18 | 0.16 | 0.19 | 16.32 |
| Mar | 0.17 | 0.15 | 0.18 | 14.49 |
| Apr | 0.18 | 0.17 | 0.20 | 10.60 |
| May | 0.17 | 0.16 | 0.19 | 14.54 |
| Jun | 0.16 | 0.14 | 0.18 | 20.27 |
| Jul | 0.14 | 0.13 | 0.15 | 17.21 |
| Aug | 0.13 | 0.12 | 0.14 | 16.74 |
| Sep | 0.12 | 0.12 | 0.14 | 14.30 |
| Oct | 0.13 | 0.11 | 0.14 | 20.39 |
| Nov | 0.13 | 0.13 | 0.14 | 9.13 |
| Dec | 0.15 | 0.13 | 0.17 | 18.72 |
Aptevo Therapeutics information and performance
2401 4TH AVE., SUITE 1050, SEATTLE, WA, US
Market capitalization of the Aptevo Therapeutics Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of APVO shares in the company outstanding by the market price of one share.
EBITDA of Aptevo Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Aptevo Therapeutics (APVO) stock dividend
Aptevo Therapeutics last paid dividends on 01/01/1970. The next scheduled payment will be on 03/27/2020. The amount of dividends is $None per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
